DRAK1 Peptide

• NCBI Gene ID:

  9263

• Swiss Prot:

  Q9UEE5

• Accession Number:

  Q9UEE5

• Type:

  Peptides

• Concentration:

  200 ug/mL

• Buffer:

  PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store DRAK1 peptide at -20˚ C, stable for one year.

• Applications Notes:

  DRAK1 peptide is used for blocking the activity of DRAK1 antibody.

• NCBI Official Name:

  Serine/threonine kinase 17a

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Sanjo H, Kawai T, Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 1998;273:29066-71.

• Background Reference 02:

  Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) . J Biol Chem 1997;272:7727-31

• Background Reference 03:

  Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 1997;272:27730-6 (RD1299)

• Other Product Names:

  DRAK1, DRAK1, DAP kinase-related apoptosis-inducing protein kinase 1

• Tested Applications:

  Blocking

• Species:

  Human

• Protein ID:

  14423930

• Physical Properties:

  Liquid